P2X7R antagonist protects against renal injury in mice with adriamycin nephropathy

Zhu,Yanji; Liu,Min; Xun,Wenlong; Li,Keliang; Niu,Xiangji

doi:10.3892/etm.2021.11084

P2X7R antagonist protects against renal injury in mice with adriamycin nephropathy

Authors:
- Yanji Zhu
- Min Liu
- Wenlong Xun
- Keliang Li
- Xiangji Niu
View Affiliations

Affiliations: Department of Pediatrics, People's Hospital of Rizhao Affiliated to Jining Medical University, Rizhao, Shandong 276800, P.R. China
Published online on: December 21, 2021 https://doi.org/10.3892/etm.2021.11084
Article Number: 161
Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Activation of the purinergic P2X7 receptor (P2X7R) has been associated with the development of experimental nephritis. Therefore, the current study aimed to explore the mechanism of P2X7R in renal injured mice with adriamycin (ADR) nephropathy. The protective effect of a P2X7R antagonist on the kidneys of mice with ADR nephropathy was also evaluated. Nephropathy was induced by a single intravenous injection of ADR (10.5 mg/kg). A total of 6 h before the model was established, the P2X7R antagonist A438079 (100, 200 and 300 µmol/kg) was injected into the mice, which was subsequently administered daily for 1 week by intraperitoneal injection. Subsequently, all mice were sacrificed, after which blood, 24 h‑urine and the kidneys were collected. The levels of albumin (ALB) and total cholesterol (TC) in the serum, along with urine protein content at 24 h were determined using an automatic biochemical analyzer. The levels of IL‑1β and IL‑18 were additionally detected in the renal tissues by ELISA. Moreover, the expression of P2X7R, oxidized (ox)‑low density lipoprotein (LDL), C‑X‑C motif chemokine ligand 16 (CXCL16), Bax, caspase‑3 and NLRP3 in renal tissues was detected by immunohistochemistry. Apoptosis in the renal tissues was observed using the TUNEL assay. The results demonstrated that compared with the control group, decreased weight, increased proteinuria, decreased serum ALB and increased serum TC was observed in the ADR group. The expression of IL‑1β, IL‑18, P2X7R, ox‑LDL, CXCL16, Bax, caspase‑3 and NLRP3, as well as cellular apoptosis in the renal tissues of the ADR group, was significantly increased in the ADR group compared with the control. However, compared with the ADR group, the changes in all indices in the ADR + A438079 groups were attenuated. Overall, P2X7R, ox‑LDL and CXCL16 may be associated with ADR nephropathy, while inhibition of P2X7R may reduce the expression of ox‑LDL by downregulating the CXCL16 pathway to alleviate kidney injury in mice with ADR nephropathy. Furthermore, activated P2X7R may promote the release of inflammatory cytokines IL‑1β and IL‑18 through the downstream P2X7R/NLRP3 pathway and upregulate the expression of Bax and caspase‑3 to promote apoptosis, which participates in the process of ADR nephropathy. Inhibiting P2X7R may also reduce the release of IL‑1β and IL‑18 by downregulating the P2X7R/NLRP3 pathway, downregulating the expression of Bax and caspase‑3, and reducing apoptosis, thereby alleviating kidney injury in mice with ADR nephropathy.

View Figures

View References

1	Hao S, Wu Y, Kang Y, Niu X, Zhu G and Huang W: A single-center analysis of primary nephrotic syndrome with acute pancreatitis in children. Medicine (Baltimore). 99(e21056)2020.PubMed/NCBI View Article : Google Scholar
2	Chen A, Sheu LF, Ho YS, Lin YF, Chou WY, Chou TC and Lee WH: Experimental focal segmental glomerulosclerosis in mice. Nephron. 78:440–452. 1998.PubMed/NCBI View Article : Google Scholar
3	Manabe N, Kinoshita A, Yamaguchi M, Furuya Y, Nagano N, Yamada-Uchio K, Akashi N, Miyamoto-Kuramitsu K and Miyamoto H: Changes in quantitative profile of extracellular matrix components in the kidneys of rats with adriamycin-induced nephropathy. J Vet Med Sci. 63:125–133. 2001.PubMed/NCBI View Article : Google Scholar
4	Lydia A, Asanuma K, Nonaka K, Takagi M, Jeong KH, Kodama F, Asao R, Asanuma E, Prodjosudjadi W and Tomino Y: Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis. Am J Nephrol. 35:58–68. 2012.PubMed/NCBI View Article : Google Scholar
5	Wang YM, Wang Y, Harris DCH, Alexander SI and Lee VWS: Adriamycin nephropathy in BALB/c mice. Curr Protoc Immunol. 108:15.28.1–15.28.6. 2015.PubMed/NCBI View Article : Google Scholar
6	Adinolfi E, Giuliani AL, De Marchi E, Pegoraro A, Orioli E and Di Virgilio F: The P2X7 receptor: A main player in inflammation. Biochem Pharmacol. 151:234–244. 2018.PubMed/NCBI View Article : Google Scholar
7	Jiang LH, Baldwin JM, Roger S and Baldwin SA: Insights into the molecular mechanisms underlying mammalian P2X7 receptor functions and contributions in diseases, revealed by structural modeling and single nucleotide polymorphisms. Front Pharmacol. 4(55)2013.PubMed/NCBI View Article : Google Scholar
8	Arkhipov SN and Pavlov TS: ATP release into ADPKD cysts via pannexin-1/P2X7 channels decreases ENaC activity. Biochem Biophys Res Commun. 513:166–171. 2019.PubMed/NCBI View Article : Google Scholar
9	Wang C, Hou XX, Rui HL, Li LJ, Zhao J, Yang M, Sun LJ, Dong HR, Cheng H and Chen YP: Artificially cultivated ophiocordyceps sinensis alleviates diabetic nephropathy and its podocyte injury via inhibiting P2X7R expression and NLRP3 inflammasome activation. J Diabetes Res. 2018(1390418)2018.PubMed/NCBI View Article : Google Scholar
10	Franco M, Bautista-Pérez R, Cano-Martínez A, Pacheco U, Santamaría J, Del Valle Mondragón L, Pérez-Méndez O and Navar LG: Physiopathological implications of P2X1 and P2X7 receptors in regulation of glomerular hemodynamics in angiotensin II-induced hypertension. Am J Physiol Renal Physiol. 313:F9–F19. 2017.PubMed/NCBI View Article : Google Scholar
11	Koo TY, Lee JG, Yan JJ, Jang JY, Ju KD, Han M, Oh KH, Ahn C and Yang J: The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells. Kidney Int. 92:415–431. 2017.PubMed/NCBI View Article : Google Scholar
12	Harada H, Chan CM, Loesch A, Unwin R and Burnstock G: Induction of proliferation and apoptotic cell death via P2Y and P2X receptors, respectively, in rat glomerular mesangial cells. Kidney Int. 57:949–958. 2000.PubMed/NCBI View Article : Google Scholar
13	Sha W, Shen L, Zhou L, Xu DY and Lu GY: Down-regulation of miR-186 contributes to podocytes apoptosis in membranous nephropathy. Biomed Pharmacother. 75:179–184. 2015.PubMed/NCBI View Article : Google Scholar
14	Beaucage KL, Xiao A, Pollmann SI, Grol MW, Beach RJ, Holdsworth DW, Sims SM, Darling MR and Dixon SJ: Loss of P2X7 nucleotide receptor function leads to abnormal fat distribution in mice. Purinergic Signal. 10:291–304. 2014.PubMed/NCBI View Article : Google Scholar
15	Peng K, Liu L, Wei D, Lv Y, Wang G, Xiong W, Wang X, Altaf A, Wang L, He D, et al: P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation. Int J Mol Med. 35:1179–1188. 2015.PubMed/NCBI View Article : Google Scholar
16	Wang C, Li Q, Zhen J, Xu Y and Sun S: Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy. Int J Clin Exp Pathol. 8:15696–15707. 2015.PubMed/NCBI
17	Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, et al: Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-what is known and what is still unknown? Autoimmun Rev. 19(102671)2020.PubMed/NCBI View Article : Google Scholar
18	Gentile D, Natale M, Lazzerini PE, Capecchi PL and Laghi-Pasini F: The role of P2X7 receptors in tissue fibrosis: A brief review. Purinergic Signal. 11:435–440. 2015.PubMed/NCBI View Article : Google Scholar
19	Vonend O, Turner CM, Chan CM, Loesch A, Dell'Anna GC, Srai KS, Burnstock G and Unwin RJ: Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. Kidney Int. 66:157–166. 2004.PubMed/NCBI View Article : Google Scholar
20	Mansouri E, Assarehzadegan MA, Nejad-Dehbashi F and Kooti W: Effects of Pravastatin in adriamycin-induced nephropathy in rats. Iran J Pharm Res. 17:1413–1419. 2018.PubMed/NCBI
21	Lee VW and Harris DC: Adriamycin nephropathy: A model of focal segmental glomerulosclerosis. Nephrology (Carlton). 16:30–38. 2011.PubMed/NCBI View Article : Google Scholar
22	Lee HS: Oxidized LDL, glomerular mesangial cells and collagen. Diabetes Res Clin Pract. 45:117–122. 1999.PubMed/NCBI View Article : Google Scholar
23	Korhonen M, Ylänne J, Laitinen L and Virtanen I: The alpha 1-alpha 6 subunits of integrins are characteristically expressed in distinct segments of developing and adult human nephron. J Cell Biol. 111:1245–1254. 1990.PubMed/NCBI View Article : Google Scholar
24	Lee HS, Jeong JY, Kim BC, Kim YS, Zhang YZ and Chung HK: Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney Int. 51:1151–1159. 1997.PubMed/NCBI View Article : Google Scholar
25	Zhang G, Li Q, Wang L, Chen Y, Zhang W and Yang H: The effects of inflammation on lipid accumulation in the kidneys of children with primary nephrotic syndrome. Inflammation. 34:645–652. 2011.PubMed/NCBI View Article : Google Scholar
26	Moorhead JF, Chan MK, El-Nahas M and Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 2:1309–1311. 1982.PubMed/NCBI View Article : Google Scholar
27	Vaziri ND, Navab M and Fogelman AM: HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol. 6:287–296. 2010.PubMed/NCBI View Article : Google Scholar
28	Hu ZB, Chen Y, Gong YX, Gao M, Zhang Y, Wang GH, Tang RN, Liu H, Liu BC and Ma KL: Activation of the CXCL16/CXCR6 pathway by inflammation contributes to atherosclerosis in patients with end-stage renal disease. Int J Med Sci. 13:858–867. 2016.PubMed/NCBI View Article : Google Scholar
29	Di Virgilio F: The therapeutic potential of modifying inflammasomes and NOD-like receptors. Pharmacol Rev. 65:872–905. 2013.PubMed/NCBI View Article : Google Scholar
30	Ogura Y, Sutterwala FS and Flavell RA: The inflammasome: First line of the immune response to cell stress. Cell. 126:659–662. 2006.PubMed/NCBI View Article : Google Scholar
31	Turner CM, Tam FW, Lai PC, Tarzi RM, Burnstock G, Pusey CD, Cook HT and Unwin RJ: Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol Dial Transplant. 22:386–395. 2007.PubMed/NCBI View Article : Google Scholar
32	Eamshaw WC, Martins LM and Kaufinann SH: Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem. 68:383–424. 1999.PubMed/NCBI View Article : Google Scholar
33	Zhang Y, Yuan F, Cao X, Zhai Z, Huang G, Du X, Wang Y, Zhang J, Huang Y, Zhao J and Hou W: P2X7 receptor blockade protects against cisplatin-induced nephrotoxicity in mice by decreasing the activities of inflammasome components, oxidative stress and caspase-3. Toxicol Appl Pharmacol. 281:1–10. 2014.PubMed/NCBI View Article : Google Scholar
34	Liu L, Yang L, Chang B, Zhang J, Guo Y and Yang X: The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway. Ren Fail. 40:492–497. 2018.PubMed/NCBI View Article : Google Scholar